In the following section, we address the question of whether HAE-C1-INH patients are exposed to MRGPRX2 ligands, if they are related to triggers of HAE-C1-INH attacks, and what may account for the variability in response to potential stimulation with them. The gene discussed is MRGPRX2; the disease is hereditary angioedema.